Stimulation Therapy to Induce Mothers: Protocol for a Multicenter Randomized Controlled Trial
- PMID: 39207839
- PMCID: PMC11393510
- DOI: 10.2196/63463
Stimulation Therapy to Induce Mothers: Protocol for a Multicenter Randomized Controlled Trial
Abstract
Background: More than 1 million women have their labor induced in the United States each year, and synthetic oxytocin infusion is the most common method used. However, compared to spontaneous labor, medical induction is resource intensive, has increased obstetric risks, and is associated with less successful breastfeeding. In contrast to the endogenous oxytocin hormone, which is released in a pulsatile fashion in the brain, synthetic oxytocin is continuously infused intravenously, resulting in important limitations related to efficacy, safety, and cost. Akin to spontaneous labor contractions, infant suckling of the breast nipple is known to stimulate the pulsatile release of endogenous oxytocin from the posterior pituitary gland. Nipple stimulation therapy via an electric breast pump similarly stimulates endogenous oxytocin release and may be a favorable inpatient method for patients undergoing labor induction.
Objective: This study aims to examine whether inpatient nipple stimulation therapy is an efficacious labor induction method that increases the likelihood of spontaneous vaginal delivery and sustained breastfeeding and determine whether it is a cost-effective approach.
Methods: This is a multicenter, pragmatic, open-label, parallel-group randomized controlled trial of nulliparous patients with singleton gestations ≥36 weeks undergoing labor induction. This trial compares inpatient nipple stimulation therapy via an electric breast pump versus immediate synthetic oxytocin infusion without nipple stimulation. This trial including 988 nulliparas will provide adequate statistical power to detect clinically meaningful differences in delivery mode and breast milk as the sole source of nutrition for newborns at hospital discharge or 72 hours after birth.
Results: The project received pilot funding in 2021 and full funding in 2023. Enrollment for this study began in November 2021 at a single site, and as of May 2024, recruitment is underway at 3 study sites. It is anticipated that enrollment will be completed by late 2026.
Conclusions: Successful completion of this trial will provide rigorous data to determine whether inpatient nipple stimulation therapy with an electric breast pump can improve the way we induce labor and positively impact breastfeeding success and early infant nutrition through lactation.
Trial registration: ClinicalTrials.gov NCT05079841; https://clinicaltrials.gov/study/NCT05079841.
International registered report identifier (irrid): DERR1-10.2196/63463.
Keywords: breast pump; labor induction; lactation; nipple stimulation; nipple stimulation therapy; oxytocin.
©Danna Tortal, Veronika Shabanova, Sarah Taylor, Xiao Xu, Molly McAdow, Bethany Stetson, Sarah McCollum, Ester Sanchez, Amie Adjakple, Jessica Leventhal, Moeun Son. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 29.08.2024.
Conflict of interest statement
Conflicts of Interest: XX has received honoraria from the American Association of Gynecologic Laparoscopists (AAGL).
Similar articles
-
Intrapartum nipple stimulation therapy for labor induction: a randomized controlled external pilot study of acceptability and feasibility.Am J Obstet Gynecol MFM. 2022 Mar;4(2):100575. doi: 10.1016/j.ajogmf.2022.100575. Epub 2022 Jan 15. Am J Obstet Gynecol MFM. 2022. PMID: 35042047 Clinical Trial.
-
The Effect of Uterine and Nipple Stimulation on Induction With Oxytocin and the Labor Process.Worldviews Evid Based Nurs. 2015 Oct;12(5):273-80. doi: 10.1111/wvn.12116. Worldviews Evid Based Nurs. 2015. PMID: 26444882 Clinical Trial.
-
Induction of labor with an electric breast pump.J Reprod Med. 1986 Feb;31(2):116-8. J Reprod Med. 1986. PMID: 3959016
-
Tafoxiparin, a novel drug candidate for cervical ripening and labor augmentation: results from 2 randomized, placebo-controlled studies.Am J Obstet Gynecol. 2024 Mar;230(3S):S759-S768. doi: 10.1016/j.ajog.2022.10.013. Epub 2023 May 17. Am J Obstet Gynecol. 2024. PMID: 38462256 Review.
-
Induction of labor at full-term in pregnant women with uncomplicated singleton pregnancy: A systematic review and meta-analysis of randomized trials.Acta Obstet Gynecol Scand. 2019 Aug;98(8):958-966. doi: 10.1111/aogs.13561. Epub 2019 Mar 6. Acta Obstet Gynecol Scand. 2019. PMID: 30723915
Cited by
-
Induction of Labor: A Narrative Review on Cost Efficiency in Maternity Care.Cureus. 2024 Oct 12;16(10):e71302. doi: 10.7759/cureus.71302. eCollection 2024 Oct. Cureus. 2024. PMID: 39529780 Free PMC article. Review.
References
-
- Martin JA, Hamilton BE, Osterman MJ, Driscoll AK. Births: final data for 2019. Natl Vital Stat Rep. 2021 Apr;70(2):1–51. - PubMed
-
- Du Vigneaud V, Ressler C, Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J Biol Chem. 1953 Dec;205(2):949–57. https://linkinghub.elsevier.com/retrieve/pii/S0021-9258(18)49238-1 S0021-9258(18)49238-1 - PubMed
-
- ISMP high-alert medications in acute care settings. Institute for Safe Medication Practices (ISMP) 2024. [2024-08-08]. https://home.ecri.org/blogs/ismp-resources/high-alert-medications-in-acu... .
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical